午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

4-(2-methoxyethoxy)-N-{3-[(2-methyl-2-propen-1-yl)oxy]phenyl}benzamide

CAS No.
903443-95-8
Chemical Name:
4-(2-methoxyethoxy)-N-{3-[(2-methyl-2-propen-1-yl)oxy]phenyl}benzamide
Synonyms
4-(2-methoxyethoxy)-N-{3-[(2-methyl-2-propen-1-yl)oxy]phenyl}benzamide;Benzamide, 4-(2-methoxyethoxy)-N-[3-[(2-methyl-2-propen-1-yl)oxy]phenyl]-
CBNumber:
CB73657325
Molecular Formula:
C20H23NO4
Molecular Weight:
341.4
MDL Number:
MOL File:
903443-95-8.mol

4-(2-methoxyethoxy)-N-{3-[(2-methyl-2-propen-1-yl)oxy]phenyl}benzamide Properties

Boiling point 428.1±45.0 °C(Predicted)
Density 1.137±0.06 g/cm3(Predicted)
pka 13.29±0.70(Predicted)

4-(2-methoxyethoxy)-N-{3-[(2-methyl-2-propen-1-yl)oxy]phenyl}benzamide price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Aronis compounds c04327 4-(2-methoxyethoxy)-N-{3-[(2-methyl-2-propen-1-yl)oxy]phenyl}benzamide 903443-95-8 20mg $30 2021-12-16 Buy
Product number Packaging Price Buy
c04327 20mg $30 Buy

4-(2-methoxyethoxy)-N-{3-[(2-methyl-2-propen-1-yl)oxy]phenyl}benzamide Preparation Products And Raw materials

Raw materials

Preparation Products

4-(2-methoxyethoxy)-N-{3-[(2-methyl-2-propen-1-yl)oxy]phenyl}benzamide Suppliers

Global( 3)Suppliers
Supplier Tel Email Country ProdList Advantage
Alinda Chemical Ltd. +7 (495) 672-17-08 sale@alinda.ru Russia 68136 55
Supplier Advantage
Alinda Chemical Ltd. 55
4-(2-methoxyethoxy)-N-{3-[(2-methyl-2-propen-1-yl)oxy]phenyl}benzamide Benzamide, 4-(2-methoxyethoxy)-N-[3-[(2-methyl-2-propen-1-yl)oxy]phenyl]- 903443-95-8
This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept